Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 94
2010 95
2011 172
2012 153
2013 148
2014 116
2015 132
2016 139
2017 145
2018 137
2019 151
2020 161
2021 173
2022 137
2023 80

Text availability

Article attribute

Article type

Publication date

Search Results

1,960 results

Results by year

Filters applied: . Clear all
Page 1
Immunonutrition in patients with colon cancer.
Sánchez-Guillén L, Arroyo A. Sánchez-Guillén L, et al. Immunotherapy. 2020 Jan;12(1):5-8. doi: 10.2217/imt-2019-0179. Epub 2020 Jan 6. Immunotherapy. 2020. PMID: 31902282 Free article. No abstract available.
Immunotherapy for gastric cancer: a 2021 update.
Kole C, Charalampakis N, Tsakatikas S, Kouris NI, Papaxoinis G, Karamouzis MV, Koumarianou A, Schizas D. Kole C, et al. Immunotherapy. 2022 Jan;14(1):41-64. doi: 10.2217/imt-2021-0103. Epub 2021 Nov 17. Immunotherapy. 2022. PMID: 34784774 Review.
Immunotherapy in atopic dermatitis.
Li W, Man XY. Li W, et al. Immunotherapy. 2022 Oct;14(14):1149-1164. doi: 10.2217/imt-2022-0054. Epub 2022 Aug 31. Immunotherapy. 2022. PMID: 36046941 Review.
A global picture: therapeutic perspectives for COVID-19.
Chavda VP, Kapadia C, Soni S, Prajapati R, Chauhan SC, Yallapu MM, Apostolopoulos V. Chavda VP, et al. Immunotherapy. 2022 Apr;14(5):351-371. doi: 10.2217/imt-2021-0168. Epub 2022 Feb 21. Immunotherapy. 2022. PMID: 35187954 Free PMC article. Review.
Immunotherapy for cholangiocarcinoma: a 2021 update.
Charalampakis N, Papageorgiou G, Tsakatikas S, Fioretzaki R, Kole C, Kykalos S, Tolia M, Schizas D. Charalampakis N, et al. Immunotherapy. 2021 Sep;13(13):1113-1134. doi: 10.2217/imt-2021-0126. Epub 2021 Jun 30. Immunotherapy. 2021. PMID: 34190581 Review.
Deucravacitinib in moderate-to-severe psoriasis.
Vu A, Maloney V, Gordon KB. Vu A, et al. Immunotherapy. 2022 Nov;14(16):1279-1290. doi: 10.2217/imt-2022-0109. Epub 2022 Nov 14. Immunotherapy. 2022. PMID: 36373503 Review.
1,960 results